KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 162 filers reported holding KURA ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,413,977 | +0.5% | 703,287 | +16.6% | 1.17% | +17.2% |
Q2 2023 | $6,382,776 | -13.5% | 603,287 | 0.0% | 1.00% | -19.1% |
Q1 2023 | $7,378,200 | +6.5% | 603,287 | +8.1% | 1.23% | -17.1% |
Q4 2022 | $6,928,342 | -35.8% | 558,287 | -29.3% | 1.49% | -0.7% |
Q3 2022 | $10,791,000 | +19.0% | 789,952 | +59.7% | 1.50% | +54.4% |
Q2 2022 | $9,066,000 | -8.8% | 494,595 | -20.0% | 0.97% | -31.0% |
Q1 2022 | $9,941,000 | -14.7% | 618,244 | -25.7% | 1.40% | +9.7% |
Q4 2021 | $11,651,000 | -21.1% | 832,238 | +5.5% | 1.28% | +3.2% |
Q3 2021 | $14,773,000 | -18.5% | 788,735 | -9.2% | 1.24% | +1.3% |
Q2 2021 | $18,116,000 | -10.7% | 868,886 | +21.1% | 1.22% | -21.3% |
Q1 2021 | $20,291,000 | +31.8% | 717,751 | +52.2% | 1.56% | +13.8% |
Q4 2020 | $15,399,000 | +39.8% | 471,494 | +31.2% | 1.37% | +26.3% |
Q3 2020 | $11,015,000 | +26.4% | 359,494 | -32.7% | 1.08% | +32.1% |
Q2 2020 | $8,712,000 | +36.0% | 534,494 | +51.9% | 0.82% | -7.2% |
Q2 2018 | $6,406,000 | +3.5% | 351,953 | +6.7% | 0.88% | -6.0% |
Q1 2018 | $6,188,000 | – | 330,000 | – | 0.94% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |